Discovery of pre-therapy 2-deoxy-2-18F-fluoro-D-glucose positron emission tomography-based radiomics classifiers of survival outcome in non-small-cell lung cancer patients. (2019)
Attributed to:
Development of Metabolism Radiotracers to Probe Disease Pathology in Human Subjects with Cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s00259-018-4139-4
PubMed Identifier: 30173391
Publication URI: http://europepmc.org/abstract/MED/30173391
Type: Journal Article/Review
Volume: 46
Parent Publication: European journal of nuclear medicine and molecular imaging
Issue: 2
ISSN: 1619-7070